127 Western Ave
6 articles with Tectonic Therapeutic
7/23/2021Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.
Tectonic Therapeutic today announced that Dr. Marcella (“Marcie”) Ruddy, MD has been appointed Chief Medical Officer.
Vida Ventures III will approach investments the same way its first two funds do, identifying and investing in what they believe to be transformative biomedical innovative companies.
5/28/2021Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Tectonic Therapeutic , a pre-clinical stage biotechnology company transforming the discovery of novel G-protein-coupled receptors (GPCR)-targeted therapies, today announced that Peter McNamara, PhD has been appointed Senior Vice President, Head of Research.
Tectonic Therapeutic Launches with $80 Million Series A Financing to Transform the Discovery of Novel G-Protein Coupled Receptor (GPCR)-Targeted Therapies
Series A financing co-led by Vida Ventures, T.A. Springer, and Polaris Partners with participation from EcoR1 Capital Tectonic’s proprietary technology platform based on pioneering work from the Harvard lab of co-founder, Andrew Kruse, PhD Industry veteran Alise Reicin, MD named President and Chief Executive Officer